Glucagon-like peptide-1 - Amylin
Alternative Names: AC 2592; GLP-1; GLP-1 - AmylinLatest Information Update: 25 Sep 2021
At a glance
- Originator Amylin Pharmaceuticals
- Class Glucagon-like peptides
- Mechanism of Action Glucagon-like peptide-1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Diabetes mellitus; Heart failure